API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761104
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761104
https://www.nasdaq.com/articles/ema-accepts-regulatory-submission-for-lumoxiti-in-relapsed-or-refractory-hcl-2020-01-02
https://www.fiercepharma.com/pharma/astrazeneca-s-calquence-treads-imbruvica-s-turf-second-ph3-cll-win
https://endpts.com/astrazeneca-vet-jennifer-butler-takes-charge-of-innate-pharmas-us-biz-c4-raids-nibr/
http://www.pharmafile.com/appointment/520394/innate-pharma-hires-jennifer-butlers-lead-commercialisation-leukaemia-drug-lumoxi
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761104
https://www.fiercepharma.com/manufacturing/astrazeneca-lays-off-210-workers-colorado-as-it-closes-2-ex-amgen-plants
https://www.reuters.com/article/us-astrazeneca-innate-pharma/astrazeneca-digs-deeper-into-cancer-with-innate-stake-idUSKCN1MX0FK